Jiangsu Aidea Pharmaceutical Group Co., Ltd.

¥11.77As of Sun 8 Nov 2026, 12:00 UTC
SSE:688488Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (18.29%)
Div yield —
ROE 2.30%
Biotechnology
Beta (5Y) 0.65
PE TTM 763.1
TSR TTM (21.17%)
Mkt cap ¥4.953B
ROIC 3.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥14
20.06%
65.26%
Hold 11|6|5|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.19
0.19
0.20
25.89%
25.11%
14.78%
15.99%
Revenue¥M
525.0
546.7
552.7
548.8
0.66%
7.26%
5.33%
5.60%
Peers (US$742.4M)
Cap (US$)
PE
740.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.830
1.439
1.248
EBIT/Intx
0.607
0.332
0.275
Own earn%
(277.93)
(7.88)
(27.41)
Sh yield%
9.07
38.49
42.04
Owners
Insiders/Inst%
6.53
57.35
Short interest%
4.79
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
15